CY1114683T1 - COMPOSITIONS AND METHODS OF PREPARATION OF COMPOSITION - Google Patents

COMPOSITIONS AND METHODS OF PREPARATION OF COMPOSITION

Info

Publication number
CY1114683T1
CY1114683T1 CY20131101068T CY131101068T CY1114683T1 CY 1114683 T1 CY1114683 T1 CY 1114683T1 CY 20131101068 T CY20131101068 T CY 20131101068T CY 131101068 T CY131101068 T CY 131101068T CY 1114683 T1 CY1114683 T1 CY 1114683T1
Authority
CY
Cyprus
Prior art keywords
ctla4
compositions
methods
preparation
composition
Prior art date
Application number
CY20131101068T
Other languages
Greek (el)
Inventor
Kirk J Leister
Eugene J Schaefer
Ronald Bates
Elizabeth A Bramhall
David M Didio
Robert Donaldson
Alan R Flesher
Helen G Haggerty
David H Kirkley
John M Tabor
Lee K Tay
Pallaiah Thammana
Ajoy Velayudhan
David E Smolin
Reb J Russell
Boom Thomas Vanden
Jeffrey Schrimsher
Joyce Whitehead
Dean Brownell
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06848052.4A external-priority patent/EP1969007B1/en
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of CY1114683T1 publication Critical patent/CY1114683T1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η εφεύρεση παρέχει κύτταρα θηλαστικού ικανά παραγωγής ανασυνδυασμένης CTLA4-Ig και παραλλαγές αυτής. Η εφεύρεση επίσης παρέχει συνθέσεις που περιλαμβάνουν CTLA4-Ig και συνταγοποιήσεις αυτής. Η εφεύρεση περαιτέρω παρέχει μεθόδους για μαζική παραγωγή CTLA4-Ig από κύτταρα θηλαστικού ικανά παραγωγής αυτής της ανασυνδυασμένης πρωτεΐνης και για καθαρισμό της CTLA4-Ig.The invention provides mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides compositions comprising CTLA4-Ig and formulations thereof. The invention further provides methods for mass production of CTLA4-Ig from mammalian cells capable of producing this recombinant protein and for purification of CTLA4-Ig.

CY20131101068T 2005-12-20 2013-11-27 COMPOSITIONS AND METHODS OF PREPARATION OF COMPOSITION CY1114683T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75226705A 2005-12-20 2005-12-20
US75215005A 2005-12-20 2005-12-20
US84954306A 2006-10-05 2006-10-05
EP06848052.4A EP1969007B1 (en) 2005-12-20 2006-12-19 Compositions and methods for producing a composition

Publications (1)

Publication Number Publication Date
CY1114683T1 true CY1114683T1 (en) 2016-10-05

Family

ID=58448788

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131101068T CY1114683T1 (en) 2005-12-20 2013-11-27 COMPOSITIONS AND METHODS OF PREPARATION OF COMPOSITION

Country Status (1)

Country Link
CY (1) CY1114683T1 (en)

Similar Documents

Publication Publication Date Title
CY1114887T1 (en) COMPOSITIONS AND METHODS OF PREPARATION OF COMPOSITION
CY1120994T1 (en) INNOVATIVE SOLUTION COMPOSITIONS CONTAINING CELLULAR AGENTS AND USING THEM FOR WOUND TREATMENT
CY1113199T1 (en) STABILIZED GLUCOSEREMPRODUCTION COMPOSITIONS
EA200802170A1 (en) LYOPHILIZED COMPOSITION OF THERAPEUTIC PEPTIDE ANTIBODY
CY1118454T1 (en) ORIGINAL PYROLLI INHIBITORS OF S-NITROZOGLUTATHYONE PRODUCTION AS THERAPEUTIC AGENTS
CY1117710T1 (en) Crystalline Suspensions of Epoxy-Ketone Peptide Proteins and the Composition of Keto-Epoxide Amino Acids
NO20074823L (en) Rasagilin formulations with improved content uniformity
ATE528989T1 (en) CRYSTALLINE SOLID RASAGILIN BASE
CY1109010T1 (en) c-crystalline form of hydrochloride ivabradine, its preparation method and the pharmaceutical compositions containing it
MX2007005221A (en) Ascomycin crystalline forms and preparation thereof.
HN2006011218A (en) TIGECYCLINE COMPOSITIONS AND PREPARATION METHODS
HK1132760A1 (en) Site specific incorporation of non-natural amino acids by vertebrate cells
EA201270528A1 (en) COMPOSITIONS OF CYTOKINES IL-17 FAMILIES AND THEIR APPLICATION
MY163480A (en) Sclerostin binding agents
CY1110926T1 (en) Substituted Rocket Pyridines, Compositions Containing them, Preparation Procedure and Use
NO20076687L (en) Oral dosage form
MX2009004862A (en) Stabilization of vaccines by lyophilization.
EA200701293A1 (en) THERAPEUTIC COMPOSITION OF THE GROWTH FACTOR OF KERATINOCYTES
EA200800393A1 (en) NEW COMPOUNDS-ANALOGUES OF CAMPTOTECINE, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BR0211761A (en) depsipeptides and processes for preparing them
EA200601596A1 (en) IMPROVED 6-MERCAPTOPURIN COMPOSITION
EA200600403A1 (en) KLADRIBIN PREPARATIONS FOR IMPROVED ORAL DELIVERY AND DELIVERY THROUGH SLEDGE SHELLS
ATE549353T1 (en) ACTIVE VARIANTS OF IL-18 BINDING PROTEIN AND THEIR MEDICAL USES
EA200701867A1 (en) QUINOLINOUS COMPOUNDS AS AGONISTS OF 5-HT RECEPTOR
MEP34308A (en) Oral formulations of cladribine